Display options
Cite
Wedegaertner H, Pan WA, Gonzalez CC, et al. The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer. Antioxid Redox Signal. 2022;doi: 10.1089/ars.2021.0193.
Wedegaertner, H., Pan, W. A., Gonzalez, C. C., Gonzalez, D. J., & Trejo, J. (2022). The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer. Antioxidants & redox signaling, . https://doi.org/10.1089/ars.2021.0193
Wedegaertner, Helen, et al. "The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer." Antioxidants & redox signaling vol. (2022). doi: https://doi.org/10.1089/ars.2021.0193
Wedegaertner H, Pan WA, Gonzalez CC, Gonzalez DJ, Trejo J. The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer. Antioxid Redox Signal. 2022 Jan 04; doi: 10.1089/ars.2021.0193. Epub 2022 Jan 04. PMID: 34465145.
Copy Download .nbib Format: NLM
Share it on

Antioxid Redox Signal. 2022 Jan 04; doi: 10.1089/ars.2021.0193. Epub 2022 Jan 04.

The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer.

Antioxidants & redox signaling

Helen Wedegaertner, Wen-An Pan, Carlos C Gonzalez, David J Gonzalez, JoAnn Trejo

Affiliations

  1. Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
  2. Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California, USA.
  3. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.

PMID: 34465145 DOI: 10.1089/ars.2021.0193

[No abstract available.]

Keywords: GPCR; Hippo pathway; PAR1; TAZ; Thrombin; YAP

Publication Types